研究論文

2022年

Saito A#, Irie T#, Suzuki Rigel#, Maemura T#, Nasser H#, Uriu K#, Kosugi Y# (#equal contribution), Shirakawa K, Sadamasu K, Kimura I, Ito J, Wu J, Iwatsuki-Horimoto K, Ito M, Yamayoshi S, Loeber S, Tsuda M, Wang L, Ozono S, Butlertanaka EP, Tanaka Y, Shimizu R, Shimizu K, Yoshimatsu K, Kawabata R, Sakaguchi T, Tokunaga K, Yoshida I, Asakura H, Nagashima M, Kazuma Y, Nomura R, Horisawa Y, Yoshimura K, Takaori-Kondo A, Imai M, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Tanaka S*, Nakagawa S*, Ikeda T*, Fukuhara T*, Kawaoka Y*, Sato K* (*equal correspondence). Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation. Nature. 603, 700-705, 2022. [論文]

​

 Okada S, Fukai Y, Tanoue Y, Nasser H, Fukuda T, Ikeda T, Saitoh H. Basic structure and cytocompatibility of giant membrane vesicles derived from paraformaldehyde-exposed human cells. J Biochem. 171, 339-347, 2022.

​

Suzuki R, Yamasoba D, Kimura I, Wang L, Kishimoto M, Ito J, Morioka Y, Nao N, Nasser H, Uriu K, Kosugi Y, Tsuda M, Orba Y, Sasaki M, Shimizu R, Kawabata R, Yoshimatsu K, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Sawa H, Ikeda T, Irie T, Matsuno K, Tanaka S, Fukuhara T, Sato K. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant. Nature. 603, 700-705, 2022. [論文].

​

Meng B, Abdullahi A, Ferreira IATM, Goonawardane N, Saito A, Kimura I, Yamasoba D, Gerber PP, Fatihi S, Rathore S, Zepeda SK, Papa G, Kemp SA, Ikeda T, Toyoda M, Seng TT, Kuramochi J, Mitsunaga S, Ueno T, Shirakawa K, Takaori-Kondo A, Brevini T, Mallery DL, Charles OJ, CITIID-NIHR BioResource COVID-19 Collaboration, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Bowen JE, Joshi A, Walls AC, Jackson L, Martin D, Smith KGC, Bradley J, Briggs JAG, Choi J, Madissoon E, Meyer K, Mlcochova P, Ceron-Gutierrez L, Doffinger R, Teichmann SA, Fisher AJ, Pizzuto MS, de Marco A, Corti D, Hosmillo M, Lee JH, James LC, Thukral L, Veesler D, Sigal A, Sampaziotis F, Goodfellow IG, Matheson NJ, Sato K, Gupta RK. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts tropism and fusogenicity. Nature. 603, 706-714, 2022. [論文].

​

Rajib SA, Ogi Y, Hossain MB, Ikeda T, Tanaka E, Kawaguchi, Satou Y. A SARS-CoV-2 Delta variant containing mutation in the probe binding region used for RT-qPCR test in Japan exhibited atypical PCR amplification and might induce false negative result. J Infect Chemother. 28, 669-667, 2022.

​

Yamasoba D#, Kimura I#, Nasser H#, Morioka Y#, Nao N#, Ito J#, Uriu K#, Tsuda M#, Zahradnik J# (#equal contribution), Shirakawa K, Suzuki R, Kishimoto M, Kosugi Y, Kobiyama K, Hara T, Toyoda M, Tanaka YL, Butlertanaka EP, Shimizu R, Ito H, Wang L, Oda Y, Orba Y, Sasaki M, Nagata K, Yoshimatsu K, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Kuramochi J, Seki M, Fujiki R, Kaneda A, Shimada T, Nakada T, Sakao S, Suzuki T, Ueno T, Takaori-Kondo A, Ishii KJ, Schreiber G, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Sawa H, Saito A*, Irie T*, Tanaka T*, Matsuno K*, Fukuhara T*, Ikeda T*, Sato K* (*equal correspondence). Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike. Cell. 185, 2103-2115.e19, 2022. [論文]

​

Kimura I#, Yamasoba D#, Tamura T#, Nao N#, Suzuki T#, Oda Y#, Mitoma S#, Ito J#, Nasser H#, Zahradnik J#, Uriu K, Fujita S, Kosugi Y, Wang L, Tsuda M, Kishimoto M, Ito H, Suzuki R, Shimizu R, Begum MM, Yoshimatsu K, Kimura KT, Sasaki J, Sasaki-Tabata K, Yamamoto Y, Nagamoto T, Kanamune J, Kobiyama K, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Shirakawa K, Takaori-Kondo A, Kuramochi J, Schreiber G, Ishii KJ, Hashiguchi T, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Hashiguchi T*, Ikeda T*, Saito A*, Fukuhara T*, Tanaka S*, Matsuno K*, Sato K* (*equal correspondence). Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants including BA.4 and BA.5. Cell. In press, 2022. [論文].

​

Nasser H, Shimizu R, Ito J, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Saito A, Sato K, Ikeda T*(*correspondence). Monitoring fusion kinetics of viral and target cell membranes in living cells using a SARS-CoV-2 spike protein-mediated membrane fusion assay. STAR Protoc. 3, 101773, 2022. [論文].

​

Saito A#, Tamura T#, Zahradnik J#, Deguchi S#, Tabata K#, Anraku Y#, Kimura I#, Ito J#, Yamasoba D# (#equal contribution), Nasser H, Toyoda M, Nagata K, Uriu K, Kosugi Y, Fujita S, Maya Shofa, Begum MM, Shimizu R, Oda Y, Suzuki R, Ito H, Nao N, Wang L, Tsuda M, Yoshimatsu K, Kuramochi J, Kita S, Sasaki-Tabata K, Fukuhara H, Maenaka K, Yamamoto Y, Nagamoto T, Asakura H, Nagashima M, Sadamasu K, Yoshimura K, Ueno T, Schreiber G, Takaori-Kondo A, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Shirakawa K, Sawa H, Irie T, Hashiguchi T, Takayama K, Matsuno K, Tanaka S*, Ikeda T*, Fukuhara T*, Sato K* (*equal correspondence). Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant. Cell Host Microbe. 30, 1540-1555.e15, 2022. [論文].

​

Kimura I#, Yamasoba D#, Nasser H#, Zahradnik J#, Kosugi Y#, Wu J# (#equal contribution), Nagata K, Uriu, K, Tanaka YL, Ito J, Shimizu R, Tan TS, Butlertanaka EP, Asakura H, Sadamasu K, Yoshimura K, Ueno T, Takaori-Kondo A, Schreiber G, The Genotype to Phenotype Japan (G2P-Japan) Consortium, Toyoda M, Shirakawa K, Irie T, Saito A*, Nakagawa S*, Ikeda T*, Sato K* (*equal correspondence). The SARS-CoV-2 spike S375F mutation characterizes the Omicron BA.1 variant. iScience. In press. 2022. [論文].